Vycor Medical (VYCO) Share-based Compensation Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -37.35% |
| Mar 31, 2025 | -55.37% |
| Dec 31, 2024 | -28.81% |
| Mar 31, 2024 | -55.37% |
| Dec 31, 2023 | -55.37% |
| Sep 30, 2023 | -55.37% |
| Jun 30, 2023 | -62.82% |
| Mar 31, 2023 | -34.79% |
| Dec 31, 2022 | -15.67% |
| Sep 30, 2022 | -11.77% |
| Jun 30, 2022 | -16.78% |
| Mar 31, 2022 | 58.85% |
| Dec 31, 2021 | -27.47% |
| Jun 30, 2021 | 27.77% |
| Mar 31, 2021 | -13.63% |
| Dec 31, 2020 | 16.13% |
| Sep 30, 2020 | 10.68% |
| Jun 30, 2020 | 21.55% |
| Mar 31, 2020 | 8.66% |
| Sep 30, 2019 | 17.61% |
| Jun 30, 2019 | 8.10% |
| Mar 31, 2019 | -4.57% |
| Dec 31, 2018 | -0.14% |
| Sep 30, 2018 | -1.22% |
| Jun 30, 2018 | 31.10% |
| Mar 31, 2018 | -21.74% |
| Dec 31, 2017 | -16.24% |
| Sep 30, 2017 | 29.10% |
| Jun 30, 2017 | 28.33% |
| Mar 31, 2017 | -49.31% |
| Dec 31, 2016 | 9.02% |
| Jun 30, 2016 | 43.19% |
| Mar 31, 2016 | 26.38% |
| Dec 31, 2015 | 19.42% |
| Sep 30, 2015 | 17.27% |